Author:
Zhao Changlin,Hu Fangjuan,Zhang Ganlu,Yuan Junbo,Zhang Wenjun
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. AJCC. Cancer Staging Manual. 6th ed, 2002, 169.
2. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Eng Med, 2002, 346: 126–128.
3. Wang JW, Sun Y, Liu YY, et al. Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16)in advanced nonsmall cell lung cancer patient. Chinese Clinical Oncology Education Album. Qingdao: China Ocean University Press, 2005. 83–95.
4. Scagliotti GV, Parikh P, Von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemertrexed in chemotherapy —naïve patients with advanced-stage non-small cell lung cancer. Clin Oncol, 2008, 26: 3543–3551.
5. NCCN Clinical Practice Guidelines in Oncology™ 2009. Available at: http://www.cmda.org.cn/Portals/0/Upload/Files/103216696000.pdf